Cancer therapy resistance converges on immune evasion: a unified framework from immunotherapy to targeted, endocrine, and DNA repair pathways

Journal of Experimental & Clinical Cancer Research · Published 2026-07-31 · DOI 10.1186/s13046-026-03798-0

Free full text

Authors (5)

Ha-Eun Jeong, Heesun Choi, Wan-Teck Lim, Su Bin Lim, Joon-Yong An

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Jeong, H., Choi, H., Lim, W., et al. (2026). Cancer therapy resistance converges on immune evasion: a unified framework from immunotherapy to targeted, endocrine, and DNA repair pathways. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/s13046-026-03798-0

Related articles

• Transforming tumor microenvironments: nanotechnology and gene therapy in cellular signaling and epigenetic insight into chemo-resistance · Journal of Experimental & Clinical Cancer Research · 2026 · Same journal
• Targeting the lipid desaturation network in cancer: from metabolic plasticity to precision therapeutics · Journal of Experimental & Clinical Cancer Research · 2026 · Same journal
• Inhibition of 5’-tiRNAGly restores anti-PD-1 immunotherapy efficacy via DLST-mediated OGDHL succinylation in gastric cancer · Journal of Experimental & Clinical Cancer Research · 2026 · Same journal
• Beyond conventional immune checkpoints: the LILRB axis as a dual regulator of tumor and immune cell states · Journal of Experimental & Clinical Cancer Research · 2026 · Same journal
• Bi-directional regulation between NAD/NAMPT and IFN-γ/PD-L1 axes via BRD4/IRF1 and mitochondrial respiration in metastatic cutaneous melanoma · Journal of Experimental & Clinical Cancer Research · 2026 · Same journal
• Soulangianolide A targets FAM120A to disrupt SREBP1-driven lipid metabolic reprogramming and suppress clear cell renal cell carcinoma · Journal of Experimental & Clinical Cancer Research · 2026 · Same journal
• Extracellular vesicle–mediated GALNT1/RPRD1A glycosylation axis drives immune escape and peritoneal metastasis in gastric cancer · Journal of Experimental & Clinical Cancer Research · 2026 · Same journal
• Targeting immunoglobulin superfamily member 9 (IGSF9) to overcome acute myeloid leukemia resistance to CAR-T therapy · Journal of Experimental & Clinical Cancer Research · 2026 · Same journal
• ASCL2-mediated macrophage-myofibroblast transition generates immunosuppressive CAF_7 in NSCLC bone metastases · Journal of Experimental & Clinical Cancer Research · 2026 · Same journal
• ZEB1 integrates stemness, differentiation blockade and immune suppression to orchestrate osteosarcoma aggressiveness · Journal of Experimental & Clinical Cancer Research · 2026 · Same journal